System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Emilie Lévêque is an expert in Hematology at Centre Henri Becquerel (France). Emilie Lévêque has authored 43 publications, the most recent in 2026. SLR score: 105 (community average: 125). How the SLR is computed.

LeadR Profile

Emilie Lévêque Centre Henri Becquerel France
105 ScienceLeadR Reputation 105

Unlock

Register Login
Network Map

Hematology

Subspecialties: Oncology - Nuclear Medicine - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026
Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 43

Citations

Citations: 225 1st author: 2 Last author: 0 Unique author: 0

Main journals

Hematol Oncol 5
Occup Environ Med 4
Blood Adv 3
Blood 2
Leuk Lymphoma 2

Best Journals

J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.
PMID 41979332 — cells, circulating tumor dna, lymphoma, b-cell, lymphoma, neoplasms, predictive value of tests, therapeutics, dna, b-lymphocytes		Blood Adv20260
Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.
PMID 41964148 — cells, genes, circulating tumor dna, carcinoma, squamous cell, neoplasms, squamous cell carcinoma of head and neck, dna		Int J Cancer20260
Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience.
PMID 41057236 — cells, flow cytometry, lymphoma, b-cell, lymphoma, b-lymphocytes, car-t cell		Hematol Oncol20250
Correction: Analysis of the impact of the COVID-19 pandemic on the stage at diagnosis in breast cancer patients at a French comprehensive cancer centre, through two different methods: a preliminary study.
PMID 40983724 — breast neoplasms, neoplasms, covid-19, breast, diagnosis, pandemics		Breast Cancer Res Treat20250
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine).
PMID 40754555 — breast neoplasms, neoplasms, biomarkers, maytansine, ado-trastuzumab emtansine, breast, multivariate analysis, trastuzumab		Clin Transl Oncol20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS